Health News

Rethinking Breast Cancer Screening
Doctors may now have a new — and equally effective — breast cancer screening tool in their arsenal.
A Cancer One-Two Punch
Teaching an old drug a new trick may not be so far-fetched.
New Hope for Fertility After Cancer
Young women with invasive breast cancer are often faced with a difficult choice: whether or not to undergo chemotherapy despite its risk of infertility.
Skin Tone and Skin Cancer Risk
Got a darker complexion? Here's why you should be checking the palms of your hands and soles of your feet.
FDA Narrows In on Teen Tanning
If the US Food and Drug Administration (FDA) has its way, teens nationwide will be banned from using tanning beds.
FDA Proposes Tanning Bed Ban for Underage Kids
Today, the U.S. Food and Drug Administration announced important proposed steps ‎to protect public health by preventing the use of sunlamp products (also commonly known as indoor tanning beds) by minors and reducing the risk of using these devices for adults.
A Hormone Therapy Benefit for Postmenopausal Women
Hormone therapy is often used to ease symptoms like hot flashes in postmenopausal women. But this practice may have another benefit.
Breast Cancer Rxs Go Head to Head
The current front-line treatment for early breast cancer, tamoxifen, may have met its match.
Protecting the Heart During Chemo
Chemotherapy can greatly improve cancer patients' chances of survival. But with this treatment comes a serious and equally life-threatening risk: heart failure.
A New Option for ALK-Positive Lung Cancer
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).
<< first161718192021222324last >>

REFINE